| Literature DB >> 33835307 |
Kyle P D'mello1, Lei Zhao2, Erin C Kaser1, Ziwen Zhu3, Huaping Xiao1,4, Mark R Wakefield3, Qian Bai3, Yujiang Fang5,6.
Abstract
Non-Hodgkin's lymphoma is a relatively common cancer with malignant tendencies. Although there is no current cure for the disease, research has been successful in figuring out the mechanisms of how the disease progresses, however, there is still a lot of unknowns, and more research must be done to find the ultimate cause of the disease. Interleukins and various cytokines play unique roles in the development of cancer. This review article summarizes the pathophysiology between certain interleukins and non-Hodgkin's lymphoma. Although TNF-α is not an interleukin, the article examines TNF-α due to its high correspondence with cancer. The article also describes a promising immunotherapy for the disease, while looking at immunotherapies that have been successful in other types of cancer and disease.Entities:
Keywords: IL; Interleukins; Lymphoma; Non-Hodgkin’s lymphoma; TNF-α
Year: 2021 PMID: 33835307 DOI: 10.1007/s12032-021-01504-y
Source DB: PubMed Journal: Med Oncol ISSN: 1357-0560 Impact factor: 3.064